AMICUS THERAPEUTICS, INC. — Director's Dealing 2022

Oct 11, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2022-10-09

Reporting Person: Clark David Michael (Chief People Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-10-09	Common Stock	F	5510	$10.40	Disposed	210032	Direct